Page last updated: 2024-09-05

ibogaine and Cancer of Colon

ibogaine has been researched along with Cancer of Colon in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Condello, M; Gallo, FR; Meschini, S; Multari, G; Pellegrini, E; Vecchiotti, D; Zazzeroni, F1
Borralho, PM; Ferreira, MU; Gomes, SE; Mulhovo, S; Paterna, A; Rodrigues, CM1

Other Studies

2 other study(ies) available for ibogaine and Cancer of Colon

ArticleYear
A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
    Toxicology and applied pharmacology, 2022, 01-01, Volume: 434

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Ibogaine; Molecular Structure; Ovarian Neoplasms; Paclitaxel

2022
Vobasinyl-Iboga Alkaloids from Tabernaemontana elegans: Cell Cycle Arrest and Apoptosis-Inducing Activity in HCT116 Colon Cancer Cells.
    Journal of natural products, 2016, 10-28, Volume: 79, Issue:10

    Topics: Africa; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle; Cell Cycle Checkpoints; Colonic Neoplasms; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; Ibogaine; Indole Alkaloids; L-Lactate Dehydrogenase; Molecular Conformation; Molecular Structure; Mozambique; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Plants, Medicinal; Tabernaemontana

2016